Month: December 2020

Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties

– Agios to Dedicate All Resources to Advancing Mitapivat as a Potential Treatment for Three Initial Hemolytic Anemias and Building...

UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma

Initiation of innovative clinical trial focused on reducing complications and enhancing patient recovery following trauma at Memorial Hermann-Texas Medical Center,...

Grapefruit USA, Inc. Announces Commencement of Retail Distribution of its Patented “Hourglass by Grapefruit(TM)” Disruptive Time Release THC+Cannabinoid-loaded Delivery Cream in Greater Los Angeles

error: Content is protected !!